LAVA Therapeutics N.V. (LVTX)

LAVA Therapeutics Revenue

LAVA Therapeutics had revenue of 6.99M EUR in the quarter ending March 31, 2024, with 471.24% growth. This brings the company's revenue in the last twelve months to 12.54M, down -36.01% year-over-year. In the year 2023, LAVA Therapeutics had annual revenue of 6.77M, down -65.09%.

• Revenue (ttm): 12.54M EUR
• Revenue Growth: -36.01%
• P/S Ratio: 4.03
• Revenue / Employee: 338,838 EUR
• Employees: 37
• Market Cap: 54.42M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	6.77M	-12.62M	-65.09%
Dec 31, 2022	19.39M	14.04M	262.45%
Dec 31, 2021	5.35M	1.60M	42.78%
Dec 31, 2020	3.75M	-	-
Jan 1, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.